- ICH GCP
- EU: s kliniska prövningsregister
Senaste försöken
EudraCT Number: 2004-001054-84 | Sponsor Protocol Number: 2004/W/GI/02 | Start Date: 2005-02-16 | ||||||
Sponsor Name: NHS Lothian- University Hospitals Division | ||||||||
Full Title: A comparison of the efficacy of dietary hydroxypropylcellulose and questran as therapeutic agents in bile acid induced diarrhoea | ||||||||
Medical condition: these patients will have bile acid induced diarrhoea identified by an increased serum 7a-OH-cholestenone. and will have a history of one of 1. ileal resection 2. idiopathic bile acid diarrhoea.3. ... | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: GB (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-001854-10 | Sponsor Protocol Number: BO18039 | Start Date: 2005-02-16 | ||||||
Sponsor Name: F. Hoffmann-La Roche Ltd | ||||||||
Full Title: Randomized, two arm, placebo controlled double dummy study to compare the efficacy of intravenous loading doses followed by maintenance treatment with oral ibandronic acid versus zoledronic acid in... | ||||||||
Medical condition: Metastatic Bone Pain | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: HU (Completed) GB (Completed) DE (Prematurely Ended) IT (Prematurely Ended) | ||||||||
Trial results: View results |
EudraCT Number: 2004-002453-31 | Sponsor Protocol Number: AC-054-201 | Start Date: 2005-02-15 | ||||||
Sponsor Name: Actelion Pharmaceuticals Ltd. | ||||||||
Full Title: A Phase IIb, multi-center, international, double-blind, randomized, placebo-controlled, parallel-group, dose-finding study for the prevention of cerebral vasospasm after aneurysmal subarachnoid hem... | ||||||||
Medical condition: Prevention of ischaemic complications related to vasospasm in patients with aneurysmal subarachnoid haemorrhage | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: AT (Completed) SE (Completed) FI (Completed) DE (Completed) IT (Completed) BE (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-004633-33 | Sponsor Protocol Number: bosex | Start Date: 2005-02-15 | ||||||
Sponsor Name: Sexological Clinic, Rigshospitalet | ||||||||
Full Title: local botox administration on patients with vulvar vestbulitis | ||||||||
Medical condition: Vulvar vestibulits | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||
Trial protocol: DK (Completed) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2005-000290-22 | Sponsor Protocol Number: | Start Date: 2005-02-15 | ||||||
Sponsor Name: TÜ Kardioloogiakliinik | ||||||||
Full Title: Endoteeli funktsiooni hindamiskompleksi (pulsilaine analüüs, koronarograafia, immunohistokeemilised meetodid, biomarkerid) teaduslik väljatöötamine ja juurutamine kliinilises praktikas | ||||||||
Medical condition: | ||||||||
|
||||||||
Population Age: Adults | Gender: Male | |||||||
Trial protocol: EE (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2005-000040-85 | Sponsor Protocol Number: HCC01 | Start Date: 2005-02-15 | ||||||
Sponsor Name: Medical School Hannover [...] 1. Medical School Hannover 2. Medical School Hannover | ||||||||
Full Title: Erbitux Monotherapie bei Patienten mit lokoregional nicht behandelbarem Hepatozellulären Karzinom | ||||||||
Medical condition: advanced hepatocellular carcinoma (hcc) not amandable to regional therapies or metastatic disease | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: DE (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-003616-37 | Sponsor Protocol Number: M48P3 | Start Date: 2005-02-15 | ||||||
Sponsor Name: Chiron Behring GmbH & Co KG | ||||||||
Full Title: M48P3: A phase IV, randomized, controlled, single-blind, multi-center study in children to evaluate the safety, tolerability and immunogenicity of two TBE vaccines administered according to two dif... | ||||||||
Medical condition: TBE prophylaxis | ||||||||
|
||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |||||||
Trial protocol: DE (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-003945-41 | Sponsor Protocol Number: N/A | Start Date: 2005-02-15 | ||||||
Sponsor Name: liverpool university | ||||||||
Full Title: Pharmacogenetics of GABAergic mechanisms of benefit and harm in epilepsy: : A prospective cohort study to determine the enviromental and genetic factors associated with response to clobazam. | ||||||||
Medical condition: Epilepsy | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: GB (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-002143-27 | Sponsor Protocol Number: 1208.15 | Start Date: 2005-02-15 | ||||||
Sponsor Name: Boehringer Ingelheim Austria GmbH | ||||||||
Full Title: A double-blind, stratified, randomised, parallel, placebo-controlled, multi-centre study to compare the efficacy and safety of duloxetine hydrochloride (40mg twice a day) and tolterodine tartrate (... | ||||||||
Medical condition: Urge Urinary Incontinence (UUI) | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||
Trial protocol: AT (Completed) DK (Prematurely Ended) SE (Completed) DE (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-004201-18 | Sponsor Protocol Number: 0881A-101696 | Start Date: 2005-02-15 | ||||||
Sponsor Name: Wyeth Lederle Nordiska AB | ||||||||
Full Title: A multicenter, open-label, randomized, pilot study to evaluate the efficacy and safety of the combination of etanercept (ETN) and methotrexate and of etanercept (ETN) alone in patients with active ... | ||||||||
Medical condition: Plaque psoriasis | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: FI (Completed) DK (Completed) SE (Completed) | ||||||||
Trial results: View results |